abstract |
There are disclosed novel neuropeptide Y ligands having general formula (I) wherein the symbols W, A, D, R?1, R2, R3, R4¿ are further defined in the description. Compounds of formula (I) are agonists and antagonists of neuropeptide Y, and are therefore useful as regulators of neuropeptide Y activity and in treating disorders related thereto. |